Burning through cash at an alarming rate. Growth not matching spend. SP trending downwards on the back of massive P&D. Stay away IMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025